Folgen
Patrick Gonschorek
Patrick Gonschorek
Max Planck Institute for Terrestrial Microbiology
Bestätigte E-Mail-Adresse bei alumni.epfl.ch
Titel
Zitiert von
Zitiert von
Jahr
AQUA cloning: a versatile and simple enzyme-free cloning approach
HM Beyer, P Gonschorek, SL Samodelov, M Meier, W Weber, ...
PloS one 10 (9), e0137652, 2015
1822015
Dual-controlled optogenetic system for the rapid down-regulation of protein levels in mammalian cells
J Baaske, P Gonschorek, R Engesser, A Dominguez-Monedero, K Raute, ...
Scientific reports 8 (1), 15024, 2018
602018
Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
J Wilbs, XD Kong, SJ Middendorp, R Prince, A Cooke, CT Demarest, ...
Nature communications 11 (1), 3890, 2020
562020
Modularized CRISPR/dCas9 effector toolkit for target-specific gene regulation
M Agne, I Blank, AJ Emhardt, CG Gäbelein, F Gawlas, N Gillich, ...
ACS synthetic biology 3 (12), 986-989, 2014
422014
Thiol-to-amine cyclization reaction enables screening of large libraries of macrocyclic compounds and the generation of sub-kilodalton ligands
SS Kale, M Bergeron-Brlek, Y Wu, MG Kumar, MV Pham, J Bortoli, J Vesin, ...
Science advances 5 (8), eaaw2851, 2019
352019
Optogenetic downregulation of protein levels to control programmed cell death in mammalian cells with a dual blue-light switch
P Fischbach, P Gonschorek, J Baaske, JA Davies, W Weber, ...
Photoswitching Proteins: Methods and Protocols, 159-170, 2020
62020
Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin
P Gonschorek, A Zorzi, T Maric, M Le Jeune, M Schüttel, M Montagnon, ...
Journal of Medicinal Chemistry 65 (14), 9735-9749, 2022
12022
Comparative analyses of Netherton syndrome patients and Spink5 conditional knock-out mice uncover disease-relevant pathways
E Petrova, JM López-Gay, M Fahrner, F Leturcq, JP de Villartay, ...
Communications biology 7 (1), 152, 2024
2024
Novel inhibitors of kallikrein proteases and uses thereof
C Heinis, P Gonschorek, A Zorzi, A Hovnanian, O Gouin, E Petrova
US Patent App. 17/627,378, 2022
2022
Development of Tissue Kallikrein Inhibitors for the Treatment of Netherton Syndrome
PA Gonschorek
EPFL, 2019
2019
LPPT
V Baeriswyl, S Bellotto, M Bergeron-Brlek, D Bertoldo, MP Biedermann, ...
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–11